Pheast Therapeutics

pheast.com

pheast.com • Startup • New

Startup • New

Actively hiring

Science & Engineering

Health Care

Biotechnology

Overview

Salaries

Products

People

Growth

Offices

Financials

Funding and backers

Backers

ARCH Venture Partners

Momentum

0/100

no fresh signals

Backed byfrom the funds' portfolios and accelerator catalogs

ARCH Venture Partners fund

Similar startupsby what they do, their industry and backers

Trotana Therapeutics

Trotana is developing novel oral anti-inflammatory medicines.

Macomics11-50 employees

About us At Macomics we are applying our world-leading understanding of macrophage biology in developing a proprietary pipeline of…

Therini BioVenture round $74.9M · 3 yr ago • Founded 2016 • 51-200 employees

Therini Bio is developing novel therapeutics based insights into the role of fibrin in driving chronic innate immune activation.

CREATE MedicinesSeries B $122M · 4 mo ago • Founded 2021

CREATE Medicines is pioneering in vivo immune cell programming with RNA powered, LNP delivered CAR therapies – unlocking scalable…

NK:IOSeed $1.5M · 3 yr ago

By harnessing the potential of the innate immune system, we are developing ground breaking NK cell and small molecule therapies. Learn More…

Magnet Biomedicine2 roles

Magnet Biomedicine is advancing monovalent molecular glue inhibitors (MGIs) and innovative protein degraders to engage disease drivers.

Overview

At Pheast Therapeutics, we are developing new innate immune checkpoint inhibitors, including anti-CD24, to unleash the power of macrophages on aggressive cancers.